ArticleInvestigational new drugs2017

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

Christos Fountzilas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.